1421-65-4COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1.ClWFGNJLMSYIJWII-FJXQXJEOSA-NMelevodopa hydrochloride is an organic molecular entity.
1421-65-4DTXSID4045763CHEMBL1255756CHEBI:232320Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.
Warning
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
BeschreibungL-DOPA (Item No. 13248) is a metabolic precursor of dopamine that is capable of crossing the blood brain barrier to act as a dopamine D1 receptor agonist. It is produced from L-tyrosine by trysosine hydroxylase. In the brain, L-DOPA is converted to dopamine by the enzyme aromatic L-amino acid decarboxylase. It is conventionally used to increase dopamine concentrations in the brain as a treatment for Parkinson’s disease and stroke recovery. L-DOPA methyl ester is a neutral derivative of L-DOPA formulated for increased solubility compared to the parent compound.
VerwendenL-3,4-Dihydroxyphenylalanine methyl ester hydrochloride has been used:in treating 6-hydroxydopamine induced lesions mice serotonin neuronsin tyrosinase activity in B16F10 skin melanoma cellsto test its neuroprotective effect in mesencephalic neurons
Wird geladen…